4//SEC Filing
Klingensmith Harvey Robert 4
Accession 0001209191-22-022510
CIK 0001000229other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 5:05 PM ET
Size
9.1 KB
Accession
0001209191-22-022510
Insider Transaction Report
Form 4
Klingensmith Harvey Robert
Director
Transactions
- Award
Restricted Shares
2022-04-01+5,485→ 5,485 totalExercise: $0.00→ Common Shares (5,485 underlying) - Exercise/Conversion
Common Shares
2022-04-01+4,307→ 20,741 total - Exercise/Conversion
Restricted Shares
2022-04-01−4,307→ 0 totalExercise: $0.00→ Common Shares (4,307 underlying)
Footnotes (2)
- [F1]The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2023, subject to the terms of issuance.
- [F2]The Restricted Shares vested at the end of a one-year vesting period on April 1, 2022.
Documents
Issuer
CORE LABORATORIES N V
CIK 0001000229
Entity typeother
Related Parties
1- filerCIK 0001800107
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 5:05 PM ET
- Size
- 9.1 KB